Dual Wavelength Phototherapy System

Similar documents
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Clinical characteristics

Periocular skin cancer

Learning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating

Living Beyond Cancer Skin Cancer Detection and Prevention

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

Nonmelanoma skin cancers

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Fractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses COS DERM

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Histopathology: skin pathology

Interesting Case Series. Aggressive Tumor of the Midface

General information about skin cancer

Corporate Medical Policy

Integumentary System

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Hands-on: Lasers. NonAblative Rejuvenation

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

B. Incorrect! The ectoderm does not produce the dermis. C. Incorrect! The dermis is derived from the mesoderm.

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Photodynamic Therapy (PDT) Basics and clinical applications

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Periocular Malignancies

Diagnosis and Management of Actinic Keratosis (AKs)

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Dual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

Know who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Skin disorders. Basal cell carcinoma December 2009 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig ...

PHOTOTHERAPY: WHAT DO WE KNOW AND HOW DOES IT WORK? Suite 3/36 O'Riordan Street Alexandria, Sydney NSW Australia

Eyelid basal cell carcinoma Patient information

Clinical Policy: Benign Skin Lesion Removal Reference Number: CP.MP.HN150

Non-Ablative Rejuvenation

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Skin lesions & Abrasions

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Thursday 21 st August Skin Problems

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Topical Photodynamic Therapy Using Intense Pulsed Light for Treatment of Actinic Keratosis: Clinical and Histopathologic Evaluation

Technicians & Nurses Program


EXPERIMENTAL THERMAL BURNS I. A study of the immediate and delayed histopathological changes of the skin.

Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.

CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS

NONABLATIVE RESURFACING

ICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis

NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD

Appendix D: Authorization Guidelines for Dermatology Services

Skin Cancer 101: Diagnosis and Management of the Most Common Cancer

Clinical Efficacy and Statistical Evaluation of INTRAcel Treatment

Richard Turner Consultant Dermatologist

Knowledge-Powered Medicine

Skin Cancer - Non-Melanoma

Principles of Anatomy and Physiology

A PATIENT S GUIDE to MOHS MICROGRAPHIC SURGERY

Dermatology Associates Mohs Micrographic Surgery

LUMPS AND BUMPS: AN ORGANIZED APPROACH TO DIAGNOSIS AND MANAGEMENT

fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A.

WOCN Document:

Case Report No-Needle Jet Intradermal Aminolevulinic Acid Photodynamic Therapy for Recurrent Nodular Basal Cell Carcinoma of the Nose: A Case Report

The Reverse Galeal Hinge Flap: Another Valuable Technique in the Repair of Scalp

A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ. Övermark, Meri.

Patient Guide. The precise answer for tackling skin cancer. Brachytherapy: Because life is for living

Skin Cancers Emerging Trends and Treatment Approaches

Conflicts. Objectives. University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 24 August Pediatric Dermatology 101

Chapter 11 Worksheet Code It

Wound Jeopardy: Name That Wound Session 142 Saturday, September 10 th 2011

MOHS MICROGRAPHIC SURGERY

Management of patients with melanocytic and non-melanocytic neoplasms

30 Actinic Keratosis (Solar Keratosis)

GentleFamily. GentleLASE, GentleYAG, GentleMAX & Pro Series. Banubeautylaser.com.au

Evaluation of the wound healing response post deep dermal heating by fractional RF: INTRAcel

Interesting Case Series. Rhinophyma

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Malignant Melanoma Early Stage. A guide for patients

Lid Lesions: Relax or Refer

Actinic keratosis (AK): Dr Sarma s simple guide

Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM

Skin Integrity and Wound Care

Dermatology Procedure Coding

Skin Cancer in Organ Transplant Recipients Challenges and Opportunities

LARYNGEAL DYSPLASIA. Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital

Non-melanoma Skin Cancer

STUDY. Laser-Mediated Photodynamic Therapy of Actinic Keratoses

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

Treatments used Topical including cleansers and moisturizer Oral medications:

Glistening, Skin-Colored Nodule

Lasers in Gastroenterology, Otorhinolaryngology & Pulmonology

SKIN CANCER. Most common cancer diagnosis 40% of all cancers

DERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY

1) Photodynamic therapy with topical 5 aminolevulinic acid is considered medically necessary and is covered for the treatment of:

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Using the Mohs Technique for Thin Melanomas

MULTIDIODE PDT 630 TM

Award Winning. Award Winning. FDA-Cleared. Light Therapy! LED Therapy. Illuminating Vitality

Case-Based Approach to Common Dermatologic Neoplasms

Transcription:

Dual Wavelength Phototherapy System The AKLARUS Blue and Red Combination System is an effective, drugfree alternative for treating acne & photodamaged skin. The non-invasive Aklarus treatment has been shown to significantly reduce inflammatory acne lesions. The narrow band blue light destroys the P. Acne bacteria while the Red light penetrates deeper stimulating cellular mechanisms responsible for tissue repair and regeneration. Aklarus Anti-Aging Infrared and Red Combination System is used to treat wrinkles & photodamaged skin by stimulating collagen synthesis and increasing the amount of dermal elastic fibers. Aklarus Wavelength Specifications: Blue, Red and Infrared Blue 420nm 10W+/ - 3W Total Output Standard dose 26J/ cm 2 in 20 Minutes Red 628nm 20W +/ - 3W Standard dose 52J/cm 2 in 20 Minutes Infrared 880nm 16W +/ - 3W Standard dose 42 J/cm 2 in 20 Minutes 3 N. Bacton Hill Road, Frazer, PA 19355 1-877-445-5020 Fax 610-647-6297 www.hilltherapy.com

Hill HA90D Dermatology Chair

Photodynamic Therapy for non-pigmented skin malignancies In spite of the successful use of Photodynamic Therapy for actinic keratosis using aminolevulinic acid (ALA) and blue light (410 nm) in our practice, we recognized the limitations of this treatment for more advanced lesions. The topical photosensitizer methyl aminolevulinic acid (MAL) and the Aklarus Red Light System (628 nm) were chosen based on international phototherapy research studies suggesting this combination as more efficacious for treating thicker non-pigmented skin malignancies. Patient selection for treatment was based on factors, which made surgical treatment of their disease difficult. These factors included poor patient health, advanced age, tumor size and number of tumors, location and patient preference. A summary of the MAL/PDT treatment protocol: 1) Infiltration of long acting local anesthetic block in treated area. 2) Shave, debulking of thick portions of the tumor. 3) Treatment of shaved area with a CO2 laser set at 6W superpulse intermittent for hemostasis. 4) MAL application to area with a 3 hour incubation period or a 90 minute incubation period based on absorption due to debrided area. 5) Exposure to red light (628 nm) total dose of 75 J/cm2 for 29 minutes. 6) Local wound care started in 48 hours after exposure with topical antibiotic. 7) Three day course of oral antibiotic post treatment. A treated area was allowed to heal to early epithelialization. The need for additional treatment was based on clinical response and in some cases biopsy information. Residual atypical areas were selectively treated. Delaware Plastic Surgery, PA

Subject 1 50 year old man with multiple basal cell carcinomas involving the torso and extremities. He also has multiple areas of erythematous, keratotic and nodular changes. The left anterior shin showed a keratotic nodular lesion measuring approximately 2.5 cm. This area had three treatments. Eight days after the first treatment, the central area approximately 1 cm has some granular changes and bleeding. The surrounding area showed pink epidermis. Eight days after the second treatment there was still an area of erythema and slight induration. My impression is that there were some response but not as vigorous as the first. Examination 43 days after the second treatment, showed a residual area of hyperpigmentation, slight keratotic changes and no significant nodularity. A third treatment was performed, which produced a better result. 26 days after third treatment, the area shows hyperpigmentation, pink epidermis without nodularity. A total of three treatments ere performed with a 3 hour incubation period. Treatment timeline of left anterior leg: Txt. # Time interval between treatment days 1-2 33 days 2-3 46 days Delaware Plastic Surgery, PA

Left leg before 1st treatment Left leg before 1st treatment Left leg MAL application Left leg after laser 1 treatment 8 days after 1st tx L leg 210 day after 3rd tx

Subject 2 78 year old woman who has a past medical history of moderate-to-severe cardiovascular disease. In 2009 a stent was placed secondary to an MI. She is currently on anticoagulation and also on antihypertensive medications. Examination of the mid right nosed showed a ill-defined, pearly plaque with an area of central eschar. The lesion measures approximately 1.5 x 1 cm. A biopsy revealed and infiltrative basal cell carcinoma. 7 days following her first treatment, a moderate eschar was present with mild to moderate edema. After 20 days, an exam showed the eschar was gone and significant improvement with a new epidermis. A second treatment was performed with a 3 hour incubation period. Txt.# Time interval between treatment days 1-2 51 days Examination after 17 days, following her second treatment, showed new pink epidermis with subtle nodular changes. 31 days after her last exam, showed the area progressively more pale, less nodular with slight edema. Overall, she had a very good result. Four months, 22 days after the second treatment revealed a pale scar with a 3 mm superficial vascular papule. The papule will be treated with CO2 laser. Delaware Plastic Surgery, PA

Nasal basal cell carcinoma at first txt 51 days after first txt 4 months, 22 days after 1st txt

Subject 3 85 year old woman with history of Alzheimer disease, hypertension and osteoporosis. The right upper back shows a 7 x 10.5 cm diffuse nodular papular patch. A biopsy revealed superficial nodular squamous cell carcinoma. There were superficial areas admixed with nodular areas and there was mild to moderate skin laxity in this area A total of three treatments were performed with a 3 hour incubation period. Treatment timeline: Txt. # Time interval between treatment days 1-2 14 days 2-3 60 days Eight days after her first treatment the central area of nodularity had an eschar that was cleaned and there was a small area of granulation tissue. Overall, the erythematous patch appeared less keratotic and smaller. A second treatment was performed focusing on the nodular areas. Following her second treatment exam shows an area of erythema and clearing of the areas of superficial involvement. Overall this area appeared to contract. Following the third treatment, a residual central nodular lesion remained surrounded by healed epidermis. A biopsy of the residual lesion of right upper back showed nodular infiltrating basal cell carcinoma approximately 1.5 x 2 cm. A Mohs micrographic excision was preformed followed by a primary closure. Delaware Plastic Surgery, PA

Exam at 1st txt Before 2nd treatment Debriedment 2nd txt 22 days after 1st txt Treated area after 3 txts and Mohs excision of residual central lession

Subject 4 80 year old woman with long history of sun exposure. Patient is on long-term anticoagulation for a mechanical heart valve. The right nasal dorsum showed a nodular ill-defined mass and associated subcutaneous component measuring 1 x 1.5 cm. Biopsy revealed squamous cell carcinoma. A total of two treatments performed with a three hour incubation period. Treatment Timeline: Txt. # Time interval between treatment days #1-2 20days Eight days after first treatment noted a small residual eschar and slight irregularity and erythema to the base of the lesion. Twenty days after her first treatment showed a residual, erythematous, nodular margin anteriorly and on the right side of the previous margin base. Therefore, the second treatment was performed. Ten days after her second treatment, exam revealed new pink epidermis without evidence of nodularity. Delaware Plastic Surgery, PA

Pretreatment of nasal squamous cell carcinoma Pretreatment of nasal squamous cell carcinoma MAL application First treatment of debridement following CO2 laser 9 days after 1st treatment Exam before 2nd txt Debridement of 2nd txt 176 days after 2nd txt

Subject 5 71 year old man with a past medical history significant for severe COPD. He is oxygen dependant with long term oral and inhaled steroids. Past history shows many years of treatments for pre-malignant and malignant face and scalp lesions. Treatments included cryotherapy, laser treatment, topical 5-FU, ALA/PDT and Mohs surgery with reconstruction. Scalp exam with first treatment revealed three keratotic/nodular patches, each approximately 2 cm in diameter. A single treatment with a 90 minute incubation period, which resulted in clearing of all three lesions. 50 days after treatment, previously treated areas show no evidence of nodularity with new pink epidermis. Delaware Plastic Surgery, PA

Before 1st txt 50 days after 1st txt

Subject 6 87 year old man who has had a history of multiple nasal skin malignancies, which required treatments, including Mohs surgery with reconstruction. His medical history is significant for severe cardiovascular disease, requiring anticoagulation. Nasal skin exam at first treatment sowed diffuse keratotic changes with superficial ulcerations on right inferior and superior nasal tip. After the first treatment, most of the diffuse keratotic erythematous changes were cleared, however a second treatment was performed to treat residual nodular areas on the mid-nasal tip. A total of two treatments were performed with a three hour incubation period. Treatment Timeline: Txt.# Timeline interval between treatment days 1-2 46 days One month after the second treatment, all areas cleared with pink epidermis at the mid and right nasal tip. Seven months after the second treatment, a new keratotic shallow ulcerative lesion developed on the left superior aspect of the previously treated area. This area will receive addition treatment. Delaware Plastic Surgery, PA

7 months after 2nd tx lesion developed adjacent to previously treated area Before first tx 36 days after second tx

Subject 7 70 year old man who has had a history of sun exposure and prior superficial keratotic lesion removals. The right temple shows a 1.7 cm erythematous keratotic patch that is ulcerative. A biopsy revealed a nodular basal cell carcinoma. 8 days after treatment shows new pink epidermis without nodularity in the treated area. Delaware Plastic Surgery, PA

Ulcerative nodular basal cell carcinoma at time of txt Right temple lesion at time of txt 8 days after first txt

Subject 8 76 year old man with a long history of sun exposure. He does have a history of cardiovascular disease and possible abdominal aortic aneurysm, had a Greenfield filter placed in 2005 and is currently on Coumadin. The vertex scalp shows a keratotic patch measuring approximately 1.5 cm with an associated subcutaneous component. One treatment was performed with a 90 minute incubation period. 7 days after first treatment, there is a slight depression from the eschar and some granulation tissue. No evidence of nodularity. A biopsy revealed actinic keratosis with ulceration. 55 days after treatment, the scalp exam shows new pink epidermis with minimal depression, no nodularity. Delaware Plastic Surgery, PA

Before first treatment 17 days after first treatment 55 days after txt

www.hilltherapy.com Hill Laboratories Company 3 N. Bacton Hill Road Frazer, PA 19355 Phone: 1-877-445-5020 Fax: 610-647-6297